Small dense low-density lipoprotein-cholesterol concentrations predict risk for coronary heart disease: the Atherosclerosis Risk In Communities (ARIC) study
- PMID: 24558110
- PMCID: PMC3999643
- DOI: 10.1161/ATVBAHA.114.303284
Small dense low-density lipoprotein-cholesterol concentrations predict risk for coronary heart disease: the Atherosclerosis Risk In Communities (ARIC) study
Abstract
Objective: To investigate the relationship between plasma levels of small dense low-density lipoprotein-cholesterol (sdLDL-C) and risk for incident coronary heart disease (CHD) in a prospective study among Atherosclerosis Risk in Communities (ARIC) study participants.
Approach and results: Plasma sdLDL-C was measured in 11 419 men and women of the biracial ARIC study using a newly developed homogeneous assay. A proportional hazards model was used to examine the relationship among sdLDL-C, vascular risk factors, and risk for CHD events (n=1158) for a period of ≈11 years. Plasma sdLDL-C levels were strongly correlated with an atherogenic lipid profile and were higher in patients with diabetes mellitus than non-diabetes mellitus (49.6 versus 42.3 mg/dL; P<0.0001). In a model that included established risk factors, sdLDL-C was associated with incident CHD with a hazard ratio of 1.51 (95% confidence interval, 1.21-1.88) for the highest versus the lowest quartile, respectively. Even in individuals considered to be at low cardiovascular risk based on their LDL-C levels, sdLDL-C predicted risk for incident CHD (hazard ratio, 1.61; 95% confidence interval, 1.04-2.49). Genome-wide association analyses identified genetic variants in 8 loci associated with sdLDL-C levels. These loci were in or close to genes previously associated with risk for CHD. We discovered 1 novel locus, PCSK7, for which genetic variation was significantly associated with sdLDL-C and other lipid factors.
Conclusions: sdLDL-C was associated with incident CHD in ARIC study participants. The novel association of genetic variants in PCSK7 with sdLDL-C and other lipid traits may provide new insights into the role of this gene in lipid metabolism.
Keywords: coronary disease; genome-wide association study; triglycerides.
Figures



Comment in
-
All low-density lipoprotein particles are not created equal.Arterioscler Thromb Vasc Biol. 2014 May;34(5):959-61. doi: 10.1161/ATVBAHA.114.303458. Arterioscler Thromb Vasc Biol. 2014. PMID: 24740188 No abstract available.
Similar articles
-
New automated assay of small dense low-density lipoprotein cholesterol identifies risk of coronary heart disease: the Multi-ethnic Study of Atherosclerosis.Arterioscler Thromb Vasc Biol. 2014 Jan;34(1):196-201. doi: 10.1161/ATVBAHA.113.302401. Epub 2013 Nov 14. Arterioscler Thromb Vasc Biol. 2014. PMID: 24233487 Free PMC article.
-
Association of small, dense LDL-cholesterol concentration and lipoprotein particle characteristics with coronary heart disease: A systematic review and meta-analysis.PLoS One. 2020 Nov 9;15(11):e0241993. doi: 10.1371/journal.pone.0241993. eCollection 2020. PLoS One. 2020. PMID: 33166340 Free PMC article.
-
Small Dense Low-Density Lipoprotein Cholesterol and the Risk of Coronary Heart Disease in a Japanese Community.J Atheroscler Thromb. 2020 Jul 1;27(7):669-682. doi: 10.5551/jat.51961. Epub 2019 Nov 11. J Atheroscler Thromb. 2020. PMID: 31708527 Free PMC article.
-
Small Dense Low-Density Lipoprotein Cholesterol Is the Most Atherogenic Lipoprotein Parameter in the Prospective Framingham Offspring Study.J Am Heart Assoc. 2021 Feb;10(5):e019140. doi: 10.1161/JAHA.120.019140. Epub 2021 Feb 15. J Am Heart Assoc. 2021. PMID: 33586462 Free PMC article.
-
Clinical significance of small dense low-density lipoprotein cholesterol measurement in type 2 diabetes.J Diabetes Investig. 2025 Mar;16(3):370-383. doi: 10.1111/jdi.14398. Epub 2025 Jan 7. J Diabetes Investig. 2025. PMID: 39778086 Free PMC article. Review.
Cited by
-
Association of small dense LDL serum levels and circulating monocyte subsets in stable coronary artery disease.PLoS One. 2015 Apr 7;10(4):e0123367. doi: 10.1371/journal.pone.0123367. eCollection 2015. PLoS One. 2015. PMID: 25849089 Free PMC article. Clinical Trial.
-
Lipid Profile Modulates Cardiometabolic Risk Biomarkers Including Hypertension in People with Type-2 Diabetes: A Focus on Unbalanced Ratio of Plasma Polyunsaturated/Saturated Fatty Acids.Molecules. 2020 Sep 20;25(18):4315. doi: 10.3390/molecules25184315. Molecules. 2020. PMID: 32962299 Free PMC article.
-
Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2022.J Atheroscler Thromb. 2024 Jun 1;31(6):641-853. doi: 10.5551/jat.GL2022. Epub 2023 Dec 19. J Atheroscler Thromb. 2024. PMID: 38123343 Free PMC article. No abstract available.
-
Small, Dense Low-Density Lipoprotein-Cholesterol and Atherosclerosis: Relationship and Therapeutic Strategies.Front Cardiovasc Med. 2022 Feb 10;8:804214. doi: 10.3389/fcvm.2021.804214. eCollection 2021. Front Cardiovasc Med. 2022. PMID: 35224026 Free PMC article. Review.
-
Small Dense Low-Density Lipoprotein Cholesterol Levels in Breakfast Skippers and Staple Foods Skippers.J Atheroscler Thromb. 2023 Oct 1;30(10):1376-1388. doi: 10.5551/jat.64024. Epub 2023 Mar 7. J Atheroscler Thromb. 2023. PMID: 36878535 Free PMC article.
References
-
- Grundy SM, Cleeman JI, Merz CN, Brewer HB, Jr, Clark LT, Hunninghake DB, Pasternak RC, Smith SC, Jr, Stone NJ. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation. 2004;110:227–239. - PubMed
-
- Reiner Z, Catapano AL, De Backer G, et al. ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS) Eur Heart J. 2011;32:1769–1818. - PubMed
-
- Heart Protection Study Collaborative G. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebocontrolled trial. Lancet. 2002;360:7–22. - PubMed
-
- Krauss RM, Burke DJ. Identification of multiple subclasses of plasma low density lipoproteins in normal humans. J Lipid Res. 1982;23:97–104. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- HHSN268201100009I/HL/NHLBI NIH HHS/United States
- HHSN268201100010C/HL/NHLBI NIH HHS/United States
- R01 HL059367/HL/NHLBI NIH HHS/United States
- HHSN268201100007C/HL/NHLBI NIH HHS/United States
- HHSN268201100011I/HL/NHLBI NIH HHS/United States
- U01 HG004402/HG/NHGRI NIH HHS/United States
- HHSN268201100006C/HL/NHLBI NIH HHS/United States
- HHSN268201100005I/HL/NHLBI NIH HHS/United States
- HHSN268201100007I/HL/NHLBI NIH HHS/United States
- R01 HL087641/HL/NHLBI NIH HHS/United States
- UL1 TR000371/TR/NCATS NIH HHS/United States
- HHSN268201100012C/HL/NHLBI NIH HHS/United States
- RC2 HL102419/HL/NHLBI NIH HHS/United States
- UL1 RR025005/RR/NCRR NIH HHS/United States
- HHSN268201100008C/HL/NHLBI NIH HHS/United States
- UL1 TR001079/TR/NCATS NIH HHS/United States
- HHSN268201100005G/HL/NHLBI NIH HHS/United States
- HHSN268201100008I/HL/NHLBI NIH HHS/United States
- N01 HC065226/HC/NHLBI NIH HHS/United States
- HHSN268201100011C/HL/NHLBI NIH HHS/United States
- R01 HL086694/HL/NHLBI NIH HHS/United States
- HHSN268201100009C/HL/NHLBI NIH HHS/United States
- HHSN268201100005C/HL/NHLBI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical